In our OPLS-DA analysis, higher levels of Leu were associated with the less aggressive groups (HER2-negative, low Ki-67, and luminal A) of ER-positive cancers, although the levels of Leu did not reach statistical significance in univariate analysis. Here, ESR1 is linked to cancer.